Engineers Gate Manager LP Karyopharm Therapeutics Inc. Transaction History
Engineers Gate Manager LP
- $4.27 Billion
- Q2 2024
A detailed history of Engineers Gate Manager LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 28,700 shares of KPTI stock, worth $21,812. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,700
Previous 28,700
-0.0%
Holding current value
$21,812
Previous $43,000
44.19%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding KPTI
# of Institutions
120Shares Held
64.9MCall Options Held
500KPut Options Held
99K-
Vanguard Group Inc Valley Forge, PA7.65MShares$5.82 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$3.88 Million0.56% of portfolio
-
Eversept Partners, LP New York, NY4.99MShares$3.79 Million0.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.32MShares$3.28 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$3.17 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $60.7M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...